Seaport Therapeutics, Inc SPTX
—
21.52
0.40
1.89%
as of 25 Sep
- Market cap
- $1.1B
- P/E
- 0.0×
Follow SPTX
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Jun '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+2 more TTM periods Free account |
— | — | — | 0.00% | |
| — | — | 0.00% | (52.62%) | ||
ROIC |
0.00% | 0.00% | 0.00% | (53.59%) | |
Return on Tangible Assets |
— | 0.00% | 0.00% | (43.55%) | |
Free Cash Flow per Share |
0.00 | 0.00 | (54.40) | (3.96) | |
Free Cash Flow |
— | (143.89) | (133.64) | (139.58) | |
Capital Expenditures |
— | (0.79) | — | — | |
Piotroski F-Score |
— | — | — | 0.00 | |
| Other line items | |||||
Cash ROIC |
0.00% | (31.89%) | (34.06%) | (20.06%) | |
Average Days of Payables |
— | 0.00 | 0.00 | 0.00 | |
Tax Rate |
— | — | — | 0.01 | |
Research and Development Expense of Revenue |
— | — | — | 0.00% | |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.00% | |
Share Based Compensation of Revenue |
— | — | — | 0.00% | |
Interest Coverage |
— | — | — | 0.00 | |
Operating CF/Net income |
— | 0.00 | 0.00 | 1.20 | |
Depreciation/Fixed assets |
— | (7.67) | (8.40) | (7.58) | |
Capex/Depreciation |
— | 0.25 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | — | 0.00 | 0.00 | |
Operating CF per Share |
0.00 | 0.00 | (54.40) | (3.96) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
— | 0.00 | — | — | |
Net Profit Margin |
— | — | — | 0.00% |
Columns are period end dates